ZYBK-2

N/A

Report date: 2024/11/26 15:39:41
NME

Base Information

Drug NameZYBK-2
Drug Alias NameZYBK2ZYBK-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHLA class II histocompatibility antigen, DRB1 beta chain inhibitors
TargetsHLA class II histocompatibility antigen, DRB1 beta chain
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesZydus Lifesciences Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A